Armistice Capital »

Essential Utils shares owned by Armistice Capital

Quarter-by-quarter ownership of Essential Utils (WTRG) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Essential Utils

Tip: Access up to 7 years of quarterly data

All positions including Essential Utils held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Essential Utils by Armistice Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $253k 6.6k 38.31

More positions owned by Armistice Capital

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Cytokinetics Com New (CYTK)
Agios Pharmaceuticals (AGIO)
Madrigal Pharmaceuticals (MDGL)
Ptc Therapeutics I (PTCT)
Supernus Pharmaceuticals (SUPN)
Travere Therapeutics (TVTX)
Immunovant (IMVT)
Incyte Corporation (INCY)
Neurocrine Biosciences (NBIX)
UnitedHealth (UNH)
Mineralys Therapeutics (MLYS)
Freshpet (FRPT)
Dyne Therapeutics (DYN)

View all positions for Armistice Capital

Top funds holding Essential Utils

BlackRock
Vanguard Portfolio Management
Vanguard Capital Management
State Street Corporation
Norges Bank Investment Management
Geode Capital Management
Nordea Investment Management Ab
Amundi
Millennium Management
CNH Partners
Legal & General Group
Goldman Sachs Group
Northern Trust
Antipodes Partners
Balyasny Asset Management

View all funds holding Essential Utils